CTSD and breast carcinoma: The aspartic protease cathepsin D (cath-D), a marker of poor prognosis in breast cancer [12], [13], [14], [15], [16], is overexpressed and secreted at high levels by human epithelial breast cancer cells [17], [18], [19], [20], [21], [22], [23].